Literature DB >> 23044753

Application of cell-based therapies in facial transplantation.

Maria Siemionow1, Maria Madajka, Joanna Cwykiel.   

Abstract

The main purpose of cellular therapy application in face transplantation is the continuous need for the development of new strategies that would eliminate the use of toxic immunosuppressive protocols. Cellular therapy in transplantation can significantly benefit allograft survival and shorten healing time. Cells used for a therapeutic purpose are isolated mostly from bone marrow and adipose tissues. They have the ability to proliferate and differentiate in the transplanted tissue and have immunomodulatory activity. Most of the cellular therapies such as T-regulatory, dendritic, and chimeric cells are still in the experimental stage. Molecular characterization of these cells and the mechanism of their participation in allograft acceptance and rejection are not well established and will contribute to the future of modern transplantology.

Mesh:

Year:  2012        PMID: 23044753     DOI: 10.1097/SAP.0b013e31824803a5

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  7 in total

1.  Donor Recipient Chimeric Cells Induce Chimerism and Extend Survival of Vascularized Composite Allografts.

Authors:  Joanna Cwykiel; Arkadiusz Jundzill; Aleksandra Klimczak; Maria Madajka-Niemeyer; Maria Siemionow
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-05-10       Impact factor: 4.291

2.  Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.

Authors:  M Siemionow; J Cwykiel; A Heydemann; J Garcia-Martinez; K Siemionow; E Szilagyi
Journal:  Stem Cell Rev Rep       Date:  2018-04       Impact factor: 5.739

3.  The Positive Impact of Donor Bone Marrow Cells Transplantation into Immunoprivileged Compartments on the Survival of Vascularized Skin Allografts.

Authors:  Arkadiusz Jundziłł; Aleksandra Klimczak; Erhan Sonmez; Grzegorz Brzezicki; Maria Siemionow
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-10-11       Impact factor: 4.291

4.  Facial transplantation surgery.

Authors:  Seok Chan Eun
Journal:  Arch Plast Surg       Date:  2014-03-12

Review 5.  Face transplantation: on the verge of becoming clinical routine?

Authors:  Ralf Smeets; Carsten Rendenbach; Moritz Birkelbach; Ahmed Al-Dam; Alexander Gröbe; Henning Hanken; Max Heiland
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411

6.  Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy.

Authors:  Maria Siemionow; Joanna Cwykiel; Ahlke Heydemann; Jesus Garcia; Enza Marchese; Krzysztof Siemionow; Erzsebet Szilagyi
Journal:  Stem Cell Rev Rep       Date:  2018-06       Impact factor: 5.739

7.  Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.

Authors:  Maria Siemionow; Paulina Langa; Michal Harasymczuk; Joanna Cwykiel; Magdalena Sielewicz; Jaroslaw Smieszek; Ahlke Heydemann
Journal:  Stem Cells Transl Med       Date:  2021-07-22       Impact factor: 6.940

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.